Patent · US Active

CEACAM6 CAR immune cells to treat cancers

US11242386B2 · kind B2 · utility

0Cited by
0References
22Claims
0Family size

Inventors

Key dates

Filing dateJul 17, 2017
Grant dateFeb 8, 2022
Priority date—
Expiry dateJul 17, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2510/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A chimeric antigen receptor (CAR) that binds to CEACAM6, an epitope or fragment thereof, or a variant thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.